Two Sigma Investments, LP Haleon PLC Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$9.27 - $11.41 $739,746 - $910,518	-79,800 Reduced 69.01%	35,837 $371,000
Q1 2025 May 15, 2025	SELL	$9.02 - $10.67 $783,432 - $926,742	-86,855 Reduced 42.89%	115,637 $1.19 Million
Q4 2024 Feb 14, 2025	SELL	$9.23 - $10.71 $4.86 Million - $5.64 Million	-526,712 Reduced 72.23%	202,492 $1.94 Million
Q3 2024 Nov 14, 2024	SELL	$8.32 - $10.7 $11.4 Million - $14.7 Million	-1,369,916 Reduced 65.26%	729,204 $7.71 Million
Q2 2024 Aug 14, 2024	BUY	$8.01 - $8.64 $9.92 Million - $10.7 Million	1,238,834 Added 144.0%	2,099,120 $17.3 Million

Q1 2024 May 15, 2024	BUY	$8.02 - $8.67 $6.9 Million - $7.46 Million	860,286 New	860,286 $7.3 Million
Q2 2023 Aug 14, 2023	BUY	$8.04 - $9.0 $1.93 Million - $2.16 Million	239,900 New	239,900 $2.01 Million

682

451M

114K

25.7K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.3B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.